- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imatron opens offices in Europe and Middle East
Imatron announced it has established a direct sales office in Cologne, Germany, to support sales in Central Europe.The announcement came hard on the heels of the news that the company had sold an electron-beam computed tomography scanner to a medical
Imatron announced it has established a direct sales office in Cologne, Germany, to support sales in Central Europe.
The announcement came hard on the heels of the news that the company had sold an electron-beam computed tomography scanner to a medical center in Ankara, Turkey.
The company will also have an office in Dubai, United Arab Emirates, to cover the Middle East and Africa.
Imatron has been riding a wave of record sales and media attention for its EBCT technology, but the company's stock has been languishing at or below the $2 a share level, joining other Nasdaq companies in the doldrums.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
